Virginia Retirement Systems’s Lexicon Pharmaceuticals LXRX Stock Holding History

Virginia Retirement Systems’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-109,700	Closed	-$214K	–	1145
2020 Q1	$214K	Buy	109,700 +76,400	+229%	+$227K	﹤0.01%	1006
2019 Q4	$138K	Buy	+33,300	New	+$128K	﹤0.01%	1110
2018 Q3	–	Sell	-31,300	Closed	-$376K	–	1068
2018 Q2	$376K	Sell	31,300 -37,000	-54%	-$378K	﹤0.01%	950
2018 Q1	$585K	Buy	68,300 +21,400	+46%	+$198K	0.01%	803
2017 Q4	$463K	Buy	+46,900	New	+$487K	0.01%	833
2017 Q3	–	Sell	-36,700	Closed	-$604K	–	1079
2017 Q2	$604K	Sell	36,700 -51,500	-58%	-$797K	0.01%	798
2017 Q1	$1.26M	Buy	88,200 +48,200	+121%	+$715K	0.02%	599
2016 Q4	$553K	Hold	40,000	–	–	0.01%	732
2016 Q3	$723K	Buy	40,000 +22,300	+126%	+$359K	0.01%	635
2016 Q2	$254K	Buy	+17,700	New	+$240K	﹤0.01%	852

Other funds holding LXRX

Artal Group Luxembourg $931M AUM 41.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Virginia Retirement Systems's LXRX Position: Q2 2020 in Review

Virginia Retirement Systems sold out of Lexicon Pharmaceuticals (LXRX) in Q2 2020, closing a stake of 109,700 shares — an estimated $214K sold.

Virginia Retirement Systems first reported a position in LXRX in Q2 2016 and held it in 10 quarters. The position peaked at $1.26M in Q1 2017. 108 funds tracked by Wall St. Rank hold LXRX as of Q2 2020.

Virginia Retirement Systems reported no remaining Lexicon Pharmaceuticals position as of Q2 2020 after selling out during the quarter.
Virginia Retirement Systems sold 109,700 Lexicon Pharmaceuticals shares in Q2 2020, an estimated $214K.
Virginia Retirement Systems first reported a position in Lexicon Pharmaceuticals in Q2 2016 and held it in 10 quarters.
Virginia Retirement Systems's Lexicon Pharmaceuticals position peaked at $1.26M in Q1 2017.
108 funds tracked by Wall St. Rank held Lexicon Pharmaceuticals as of Q2 2020.

Based on Virginia Retirement Systems's 13F filing for Q2 2020, filed 12 Aug 2020.